Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Cancer Type
3.2. Market Snippet by Products
3.3. Market Snippet by Technology
3.4. Market Snippet by End-Users
3.5. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Incidence of Cancers
4.1.1.2. Technology Advancement
4.1.1.3. XX
4.1.2. Restraints:
4.1.2.1. Delayed Approval of Molecular Diagnostics
4.1.2.2. Lack of Skilled People
4.1.2.3. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Epidemiology
5.3. Pipeline Analysis
5.4. Supply Chain Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Cancer Type
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type Segment
7.3. Market Attractiveness Index, By Cancer Type Segment
7.3.1. Breast Cancer*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Prostate Cancer
7.3.3. Colorectal Cancer
7.3.4. Cervical Cancer
7.3.5. Liver Cancer
7.3.6. Lung Cancer
7.3.7. Blood Cancer
7.3.8. Kidney Cancer
7.3.9. Others
8. By-Products
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products
8.3. Market Attractiveness Index, By Products Segment
8.3.1. Instruments*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Reagents & Kits
8.3.3. Others
9. By Technology
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
9.3. Market Attractiveness Index, By Technology Segment
9.3.1. Polymerase Chain Reaction (PCR)*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Transcription Mediated Amplification (TMA)
9.3.3. In Situ Hybridization
9.3.4. Sequencing
9.3.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.6. Chips and Microarrays
9.3.7. Mass Spectrometry
9.3.8. Others
10. By End-Users
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
10.3. Market Attractiveness Index, By End-Users Segment
10.3.1. Research Laboratories*
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
10.3.2. Hospitals
10.3.3. Institutes & Academics
10.3.4. Others
11. By Region
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. U.S.
11.4.7.2. Canada
11.4.7.3. Mexico
11.5. Europe
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. Germany
11.5.7.2. U.K.
11.5.7.3. France
11.5.7.4. Italy
11.5.7.5. Spain
11.5.7.6. Rest of Europe
11.6. South America
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.6.7.1. Brazil
11.6.7.2. Argentina
11.6.7.3. Rest of South America
11.7. Asia Pacific
11.7.1. Introduction
11.7.2. Key Region-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.7.7.1. China
11.7.7.2. India
11.7.7.3. Japan
11.7.7.4. Australia
11.7.7.5. Rest of Asia Pacific
11.8. Middle East and Africa
11.8.1. Introduction
11.8.2. Key Region-Specific Dynamics
11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products
11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Abbott Laboratories*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Bayer Healthcare
13.3. Becton Dickinson
13.4. Cepheid
13.5. Dako
13.6. Danaher Corporation
13.7. Qiagen N.V.
13.8. Roche Diagnostics
13.9. Siemens Healthcare
13.10. Sysmex Corporation
13.11. Beckman Coulter
13.12. bioM?rieux
13.13. bioTheranostics
13.14. Genera Biosystems
13.15. Genomic Health
13.16. Genomix Biotech
13.17. Nuvera Biosciences
13.18. Orion Genomics (LIST NOT EXHAUSTIVE)
14. DataM Intelligence
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us